Table 4

Percentage survival and morbidities for NICORE centres compared with VON centres for VLBW infants 2004–7

NICORE IrelandVON
20042005200620072004200520062007
N  =  716N  =  718N  =  659N  =  796N  =  40918N  =  46166N  =  50242N  =  54073
Survival81 (74, 86)82 (77, 91)85 (81, 90)85 (81, 91)85 (82, 90)86 (82, 90)86 (83, 91)86 (83, 91)
Survival without morbidity42 (36, 50)46 (37, 56)48 (39, 53)48 (38, 64)49 (42, 59)49 (42, 60)50 (43, 60)51 (44, 62)
Severe IVH11 (6, 13)10 (3, 16)10 (0, 13)5 (2, 6)10 (5, 13)9 (5, 13)9 (5, 12)6 (2, 7)
CLD at 36 weeks19 (13, 25)19 (12, 24)21 (7, 27)15 (6, 18)28 (16, 33)28 (14, 34)27 (14, 33)24 (12, 30)
CONS sepsis26 (13, 30)26 (16, 34)25 (15, 41)25 (10, 34)13 (5, 17)13 (5, 17)12 (4, 16)12 (3, 15)
  • Each tabulated measure includes the observed value (25th and 75th percentiles) for infants born in 2004–7 in the Neonatal Intensive Care Outcomes Research and Evaluation (NICORE) Ireland group and the Vermont Oxford Neonatal Network (VON) comparison value.